DNP 965A Topic 2 results write-up example

DPI Project: Part III Grand Canyon University Free custom sample in 24 to 48h

This DNP 965A Topic 2 sample paper presents the results of a statin outreach project as a record: patient flow, two periods compared and every named outcome, including the one that moved the wrong way. It belongs to GCU DNP 965A, DPI Project: Part III, listed as DNP-965A, required in Grand Canyon University's DNP. Flow runs from 971 patients on August 31, 2029 to 912 paired, after Moher and colleagues' CONSORT model. Characteristics of the paired cohort are given once. Every proposal outcome is reported with its denominator. The 175 unreached and 214 reached patients are compared without interpretation, and results stay free of explanation as SQUIRE guidance by Ogrinc and colleagues recommends.

CourseDNP 965A DPI Project: Part III
TopicTopic 2
Paper typeResults chapter
LengthAbout 980 words, 3 pages
FormatAPA 7 student paper
SchoolGrand Canyon University (GCU)
ProgramDNP
UpdatedOctober 2026

Free sample paper for DNP 965A Topic 2

1

Results as a Record: Patient Flow, Two Periods Compared and Every Named Outcome in a Statin Outreach Project, Including the One That Moved the Wrong Way

[Author Name]

College of Nursing and Health Care Professions, Grand Canyon University

DNP-965A: DPI Project: Part III

Topic 2 Assignment

[Instructor Name]

March 25, 2030

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

What this page is doingThe title promises a record rather than an argument, and it announces the unfavorable result so the reader looks for it. The network and data are composites; the reporting guidance is real.
2

Results as a Record: Patient Flow, Two Periods Compared and Every Named Outcome in a Statin Outreach Project, Including the One That Moved the Wrong Way

Patient Flow

On August 31, 2029, the cohort held 971 patients: every patient in that age band whose type 2 diabetes was followed at one of the network's six clinics. Fifty left on November 1, when Clinic E's adults moved to the newly opened health center next door. Two developed a contraindication and were removed under the prespecified rule, one because of pregnancy and one because of a myocardial infarction. Seven left the network individually. That left 912 patients who were measured at the start of implementation and again at its end. Flow reporting of this kind, tracing everyone eligible to everyone analyzed with each loss counted, follows the convention established for trial reports (Moher et al., 2010).

Of the 912 analyzed, 389 were not on a statin by the look-back definition on August 31, and every one of them was assigned for outreach. Care managers attempted to reach all 389 at least three times. They reached 214, or 55 percent. Of those reached, 201 went through the decision aid. After the conversation, 119 of the analyzed patients started a statin, 61 declined and 34 deferred the decision to a visit. The remaining 175 assigned patients were not reached. Eight further patients started a statin through the outreach before leaving the cohort, and 11 unreached patients started one at a routine visit, bringing total new starts in the cohort during implementation to 138.

Characteristics in the Two Periods

Table 1

Time-Varying Characteristics of the Analyzed Cohort, by Period

CharacteristicBaseline, March to August 2029Implementation, September 2029 to February 2030
Mean primary care visits per patient1.41.9
Patients with an A1c result in the period61 percent66 percent
Patients with an LDL result in the period23 percent29 percent
Prescribers in the network (full-time equivalent)31.533.0

Because the comparison follows the same 912 patients, their fixed characteristics are identical in both periods: mean age 48.1 years, 51 percent women, 68 percent commercially insured, 24 percent insured by Medicaid and 8 percent uninsured, and a median most recent A1c of 7.6 percent at cohort entry. Characteristics that vary over time are given for each period in Table 1.

Outcomes

Every outcome named in the proposal is reported below, with its denominator.

Primary outcome. The share of patients counted as on a statin under the one-year look-back rose from 523 of 912, 57.3 percent, on August 31, 2029, to 611 of 912, 67.0 percent, on February 28, 2030, a paired difference of 9.6 percentage points (95 percent confidence interval 6.9 to 12.4; McNemar chi-square 44.0, p less than 0.001). On the monthly run chart, the trend rule was met at the January value and the shift rule at the February value (Perla et al., 2011).

Secondary outcome: new starts. Month by month, starts among cohort members who began the month with no statin numbered 24, 31, 27, 22, 19 and 15 from September through February, 138 in total. The corresponding baseline months averaged 9 a month, 54 in total, counted retrospectively.

Process outcome: reach. Of 389 patients assigned for outreach, 214 were reached, 55 percent. Of 214 reached, 201 completed the decision aid, 94 percent.

Process outcome: pended orders. Of 146 orders pended, 139 were signed within seven days, 95 percent; 7 were signed later or declined by the prescriber.

Mechanism outcome. Of 214 patients reached, 58 completed the belief questionnaire at both calls, 27 percent, below the prespecified threshold of 70 percent; the outcome is therefore reported descriptively. Among the 58, the median necessity-minus-concern differential rose by 3 points among the 41 who started a statin and by 1 point among the 17 who did not.

Balancing outcome: calls or visits about muscle aches in a new starter's first three months. This measure moved against the intervention. During implementation, 19 of 138 new starters, 13.8 percent, called or visited with muscle symptoms, compared with 4 of 54 new starters in the baseline months, 7.4 percent (Fisher's exact p = 0.32). Of the 19, 9 stopped the statin, 6 continued at the same dose and 4 were switched to a different statin or a lower dose. The proportion stayed below the prespecified harm threshold of 15 percent.

What this page is doingEvery outcome the proposal named appears with its denominator, the unfavorable balancing measure gets the same space as the others, and interpretation is left for the discussion section.
3

Reached and Unreached Patients

Because 175 of the 389 patients assigned for outreach were never reached, their characteristics are reported beside those of the 214 who were, without interpretation. Mean age was 46.9 years among unreached patients and 48.6 among reached patients. Commercial insurance covered 71 percent of the unreached and 63 percent of the reached; Medicaid covered 17 and 29 percent. Among the unreached, 44 percent had no phone number marked as preferred in the record, compared with 12 percent of the reached. Among the unreached, 38 percent had been flagged by care managers as reachable only in the evening, compared with 31 percent of the reached. Unreached patients had a mean of 1.1 primary care visits in the implementation period; reached patients had 2.2.

During the implementation period, 11 of the 175 unreached patients started a statin through a routine visit without any project contact; these starts are included in the primary outcome and in the new-starts count, because both measures describe the cohort rather than the project's contacts. Among the 523 patients already on a statin on August 31, 42 no longer met the look-back definition by February 28, because their most recent fill had passed the twelve-month window.

A Note on What Follows

The results are presented without explanation, as reporting guidance for improvement work recommends, so the reader can see what happened before being told what it means (Ogrinc et al., 2016). The difference in visits between the periods, the rise in muscle symptom contacts and the gap between reached and unreached patients are all taken up in the interpretation section that follows.

References

Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010). CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, Article c869. https://doi.org/10.1136/bmj.c869

Ogrinc, G., Davies, L., Goodman, D., Batalden, P., Davidoff, F., & Stevens, D. (2016). SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): Revised publication guidelines from a detailed consensus process. BMJ Quality & Safety, 25(12), 986-992. https://doi.org/10.1136/bmjqs-2015-004411

Perla, R. J., Provost, L. P., & Murray, S. K. (2011). The run chart: A simple analytical tool for learning from variation in healthcare processes. BMJ Quality & Safety, 20(1), 46-51. https://doi.org/10.1136/bmjqs.2009.037895

DNP 965A Topic 2 instructions, in plain terms

Topic 2 in DNP-965A asks students to write the results section of their DPI Project. Strong results sections report patient flow from the starting cohort to the analyzed group, describe the characteristics of the patients compared and report every outcome named in the proposal with its denominator, including any that got worse. Students should present results without interpretation, keeping explanation for the discussion, as reporting guidelines recommend, and they may describe reached and unreached patients side by side so readers can judge who the intervention touched. Figures should match the analysis report exactly. A flow diagram or table showing how the cohort shrank, with the reason at each step, is expected, and characteristics should be reported in a table rather than in prose.

How the DNP-965A Topic 2 example is put together

The finished example reads as a record rather than as an argument. A participant flow account opens it, tracing everyone eligible through to everyone analyzed, with each loss counted and attributed. Baseline characteristics follow for both periods, and one of them differs enough that it is printed without comment for the discussion to handle later. Every outcome the proposal named then appears, primary and secondary alike, each with the denominator sitting underneath it. The secondary measure moved against the intervention and is given the same room as the others. No sentence explains, excuses or interprets anything, which is what allows a reader to reach the discussion still trusting the figures above it.

Reading the DNP 965A Topic 2 rubric

Faculty reward results reported as a record. An Excellent section traces flow from 971 to 912, modeled on CONSORT by Moher and colleagues. Credit goes to fixed characteristics reported once, such as a mean age of 48.1 years, since the same patients appear in both periods. The rubric values reporting every proposal outcome with its denominator, including a secondary outcome that moved the wrong way. Strong sections set 175 unreached beside 214 reached patients without comment. Top marks go to holding all interpretation for the discussion, as SQUIRE recommends.

DNP 965A Topic 2 help: mistakes that cost marks

The characteristic failure of this course shows up first in the results, as a section written as though the intervention plainly worked, with the inconvenient measure shortened or dropped. A second weakness is interpretation smuggled into the recording, where a figure arrives already accompanied by the reason it should be forgiven. Marks also go for proportions given without bases, since a movement from two of nine to four of eleven is not the movement a pair of percentages suggests. Participant flow that does not add up leaves a reader counting losses nobody has accounted for. Baseline differences omitted make two periods look comparable when they are not. Tables disagreeing with the text lose a committee faster than anything else available.

Get a DNP-965A Topic 2 example written to your instructions

Send the DNP-965A Topic 2 assignment instructions and the rubric your classroom posts, with the outcome list your proposal committed to. We write a custom example to those criteria, with participant flow traced, denominators attached and every measured outcome reported at the same length, in 24 to 48 hours. The first one is free.

More DNP 965A papers and DNP samples

DNP 965A Topic 2 questions, answered

Do I have to report a secondary outcome that got worse?

Yes, and at the same length as the others. The proposal named it, which means a reader can check whether it appeared. A measure that deteriorated is often the most informative thing the project produced, since it points at a cost the intervention imposed somewhere the design was not looking. Shortening it converts a finding into a concealment.

Where does interpretation belong if not the results?

In the discussion, after the reader has seen the figures unaccompanied. Keeping the two apart is a convention with a practical purpose: a committee that meets an explanation before the number it explains has no way to judge that number independently. Record first and argue second, and the argument will be read a good deal more generously.

Do you produce the numbers that go in the results?

No. The project is yours, you collected the data under your own approvals, and running the analysis is doctoral work that nobody else can do on your behalf. A sample shows the shape of the written section around results you already hold: how flow is traced, where bases sit, and how an unwelcome outcome is presented.

Where can I find a free DNP 965A Topic 2 sample paper?

The results section for DNP 965A Topic 2 covers patient flow, characteristics in the two periods, outcomes with denominators, reached and unreached patients and a note on what follows. Share your DNP 965A Topic 2 prompt for a free section.

Must an outcome that got worse be reported in DNP 965A Topic 2?

Yes, and with the same detail as the others. Every outcome named in the proposal appears, because leaving out an unfavorable one would misrepresent what happened.